Eli Lilly weight loss drug shortages underscore FDA oversight issues

The fight over tirzepatide illuminates cracks in the agency's system to monitor drug shortages

October 25, 2024 Check out STAT+

Sponsored By

Adobe STAT+ | Eli Lilly weight loss drug shortage underscores deeper issues with FDA oversight The shortage of the drug, sold as Mounjaro for diabetes and Zepbound for obesity, has raised concerns around how the agency monitors such cases. By Lizzy Lawrence, Elaine Chen, and Ed Silverman STAT+ | For the behemoth UnitedHealth, a new threat to Medicare profits UnitedHealth reaped billions from the Medicare program by diagnosing patients with serious chronic illnesses and then delivering no follow-up care. By Tara Bannow and Casey Ross In the era of GLP-1 drugs, demand for bariatric surgery plunges The findings spell an uncertain future for hospitals and clinics that derive a significant portion of their revenues from obesity procedures By Megan Molteni Ability to wed: When getting married could mean losing lifesaving medical benefits Video: A couple in love cannot get married because she'll lose her Social Security Disability Insurance: a short documentary on trying to change SSDI laws. By Jean Zamora and Varun Srikanth Being a patient can be a full-time job. This ICU nurse wants to make it easier STAT Wunderkind Michael Anne Kyle is an ICU nurse studying how tasks like navigating prior authorization impact patients' heath care. By Allessandra DiCorato Opinion: Louisiana's creative new ways to fight maternal mortality Creative care models focused on mental health could save pregnant people's lives — if they can get state and federal backing. By Nupur Jain, Nancy Hinojos, and Shawn Izadi

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser